Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

Group 1 - Orion Corporation has received a notification regarding transactions made by its board member, Karen Lykke Sørensen, under the Market Abuse Regulation [1] - The transaction involved the receipt of a share-based incentive, with a volume of 415 shares at a unit price of 0 EUR [1] - In 2024, Orion's net sales amounted to EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] Group 2 - Orion Corporation operates as a Nordic pharmaceutical company, developing, manufacturing, and marketing both human and veterinary pharmaceuticals [2] - The company has a diverse portfolio that includes proprietary and generic medicines, as well as consumer health products, focusing on oncology and pain in its pharmaceutical R&D [2] - Orion's shares are listed on Nasdaq Helsinki, indicating its presence in the public market [2]